Low-dose pulse cyclophosphamide in the treatment of neuropsychiatric lupus

Abstract

Get full access to this article

View all access options for this article.

References

The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes . Arthritis Rheum 1999; 42: 599-608 .

Ainala H , Loukkola J , Peltola J , Korpela M , Hietaharju A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus . Neurology 2001; 57: 496-500 .

Ainala H , Hietaharju A , Loukkola J et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation . Arthritis Rheum, 2001; 45: 419-423 .

Mok CC , Lau CS , Wong RW. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus . J Rheumatol 2001; 28: 766-771 .

Brey RL , Holliday SL , Saklad AR et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions . Neurology 2002; 58: 1214-1220 .

Sanna G , Bertolaccini M , Cuadrado M et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies . J Rheumatol 2003; in press.

West SG. Lupus and the central nervous system . Curr Opin Rheumatol 1996; 8: 408-414 .

DeGiorgio LA , Konstantinov KN , Lee SC , Hardin JA , Volpe BT , Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus . Nat Med 2001; 7: 1189-1193 .

Levine SR , Deegan MJ , Futrell N , Welch KM. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases . Neurology 1990; 40: 1181-1189 .

10.

Toubi E , Khamashta MA , Panarra A , Hughes GR. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus . Am J Med 1995; 99: 397-401 .

11.

Denburg SD , Carbotte RM , Ginsberg JS , Densburg JA. The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus . J Int Neuropsychol Soc 1997; 3: 377-386 .

12.

Menon S , Jameson-Shortall E , Newman SP , Hall-Craggs MR , Chinn R , Isenberg DA. A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus . Arthritis Rheum 1999; 42: 735-741 .

13.

Hanly JG , Hong C , Smith S , Fisk JD. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus . Arthritis Rheum 1999: 728-734 .

14.

Denburg SD , Carbotte RM , Denburg JA. Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus . Arthritis Rheum 1994; 37: 1311-1320 .

15.

Neuwelt CM , Lacks S , Kaye BR , Ellman JB , Borenstein DG. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus . Am J Med 1995; 98: 32-41 .

16.

Hughes G. Thrombosis, abortion, cerebral disease and the lupus anticoagulant . BMJ 1983; 287: 1088-1089 .

17.

Khamashta MA , Cuadrado MJ , Mujic F , Taub NA , Hunt BJ , Hughes GR. The management of thrombosis in the antiphospholipid-antibody syndrome . N Engl J Med 1995; 332: 993-997 .

18.

Boumpas DT , Yamada H , Patronas NJ , Scott D , Klippel JH , Balow JE. Pulse cyclophosphamide for severe neuropsychiatric lupus . Q J Med 1991; 81: 975-984 .

19.

Ramos PC , Mendez MJ , Ames PR , Khamashta MA , Hughes GR. Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus . Clin Exp Rheumatol 1996; 14: 295-299 .

20.

Baca V , Lavalle C , Garcia R et al. Favourable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus . J Rheumatol 1999; 26: 432-439 .

21.

Takada K , Illei GG , Boumpas DT. Cyclophosphamide for the treatment of systemic lupus erythematosus . Lupus 2001; 10: 154-161 .

22.

Boumpas DT , Austin HA 3rd , Vaughan EM , Yarboro CH , Klippel JH , Balow JE. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy . Ann Intern Med 1993; 119: 366-369 .

23.

Martin-Suarez I , D’Cruz D , Mansoor M , Fernandes AP , Khamashta MA , Hughes GR. Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide . Ann Rheum Dis 1997; 56: 481-487 .

24.

Stojanovich L , Stojanovich R , Kostich V , Dzjolich E. Neuropsychiatric lupus favorable response to low dose i.v. cyclophosphamide and prednisolone (pilot study) . Lupus 2003; 12: 3-7 .